OncoZenge ABOMXSTO: ONCOZ

OncoZenge: New patent application targets dental and oral pain

· Issued by OncoZenge AB

Summary by 6ix AI

Redeye Nordic Growth AB, an equity research firm, published an analyst research note on OncoZenge titled 'OncoZenge: New patent application targets dental and oral pain'.

Key details

  • Redeye Nordic Growth AB says it specializes in Nordic growth companies in tech and life science, and is part of the Redeye group, which also offers corporate finance advisory and fund management services.

6ix AI wrote this summary from the release below and checked it against the release.

Redeye’s analyst published a Research Note on OncoZenge.
Click here to read the article
Make sure to add OncoZenge to your Watchlist at Redeye and our analysts will notify you if anything relevant happens regarding your companies.

About Redeye Nordic Growth AB


This is a press release from Redeye Nordic Growth AB, a equity research firm specializing in Nordic growth companies within Tech and Life Science. Redeye Nordic Growth is a part of the Redeye group, which also offers services within corporate finance advisory and fund management. https://services.redeye.se/

Attachments


OncoZenge: New patent application targets dental and oral pain

© Modular Finance, source Nordic Press Releases

OncoZenge AB on 6ix

Story so far

Earlier from OncoZenge

Later from OncoZenge

All OncoZenge news releases